Biomarkers in anal cancer: from biological understanding to stratified treatment

被引:45
作者
Jones, Christopher M. [1 ,2 ]
Goh, Vicky [3 ,4 ]
Sebag-Montefiore, David [1 ,2 ]
Gilbert, Duncan C. [5 ]
机构
[1] Leeds Teaching Hosp NHS Trust, Leeds Canc Ctr, Leeds LS9 7TF, W Yorkshire, England
[2] Univ Leeds, Leeds Inst Canc & Pathol, Leeds LS9 7TF, W Yorkshire, England
[3] Kings Coll London, Div Imaging Sci & Biomed Engn, London SE1 7EH, England
[4] Guys & St Thomas NHS Fdn Trust, Dept Radiol, London SE1 7EH, England
[5] Royal Sussex Cty Hosp, Sussex Canc Ctr, Eastern Rd, Brighton BN2 5BE, E Sussex, England
关键词
anal cancer; chemoradiotherapy; HPV; squamous cell carcinoma of the anus; human papilloma virus; biomarkers; SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; NECK-CANCER; SURVIVAL; MUTATIONS; CHEMORADIOTHERAPY; P16(INK4A); EXPRESSION; REVEALS; HEAD;
D O I
10.1038/bjc.2016.398
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Squamous cell carcinomas of the anus and anal canal represent a model of a cancer and perhaps the first where level 1 evidence supported primary chemoradiotherapy (CRT) in treating locoregional disease with curative intent. The majority of tumours are associated with infection with oncogenic subtypes of human papilloma virus and this plays a significant role in their sensitivity to treatment. However, not all tumours are cured with CRT and there remain opportunities to improve outcomes in terms of oncological control and also reducing late toxicities. Understanding the biology of ASCC promises to allow a more personalised approach to treatment, with the development and validation of a range of biomarkers and associated techniques that are the focus of this review.
引用
收藏
页码:156 / 162
页数:7
相关论文
共 50 条
  • [21] A Prospective Cohort Study of Biomarkers in Squamous Cell Carcinoma of the Anal Canal (SCCAC) and their Influence on Treatment Outcomes
    Venchiarutti Moniz, Camila Motta
    Riechelmann, Rachel Pimenta
    Ribeiro Oliveira, Suilane Coelho
    Bariani, Giovanni Mendonca
    Rivelli, Thomas Giollo
    Ortega, Cintia
    Lima Pereira, Allan Andresson
    Meireles, Sibele Inacio
    Franco, Rejane
    Chen, Andre
    Bonadio, Renata Colombo
    Nahas, Caio
    Sabbaga, Jorge
    Coudry, Renata Almeida
    Braghiroli, Maria Ignez
    Hoff, Paulo Marcelo
    JOURNAL OF CANCER, 2021, 12 (23): : 7018 - 7025
  • [22] Invited Commentary: Biological and Clinical Insights From Epidemiologic Research Into HIV, HPV, and Anal Cancer
    Engels, Eric A.
    Madeleine, Margaret M.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2013, 178 (06) : 885 - 887
  • [23] Analysis of definitive chemo-radiation outcomes in anal cancer: insights from a tertiary cancer center in the MENA Region
    Alawabdeh, Tala
    Abuhijlih, Ramiz
    Mohamed, Issa
    Alnasraween, Saif
    Ababneh, Hazem
    Turfa, Reem
    Alsunna, Sanad
    Khzouz, Yacoub
    Abuhijla, Fawzi
    FRONTIERS IN ONCOLOGY, 2024, 13
  • [24] The emerging role of immunotherapy in the treatment of anal cancer
    Saude-Conde, Rita
    Parisi, Alessandro
    Giunta, Emilio Francesco
    Meyers, Michel
    Sclafani, Francesco
    CURRENT OPINION IN PHARMACOLOGY, 2022, 67
  • [25] Identification of prognosis biomarkers of prostatic cancer in a cohort of 498 patients from TCGA
    Chen, Zhiqiang
    Hu, Haiyi
    CURRENT PROBLEMS IN CANCER, 2019, 43 (06)
  • [26] The Influence of Systemic Inflammation on Treatment Response and Survival in Anal Squamous Cell Cancer
    Knight, K.
    Choong, J. X.
    McKee, R. F.
    Anderson, J. H.
    Horgan, P. G.
    McMillan, D. C.
    McDonald, A.
    Roxburgh, C. S.
    CLINICAL ONCOLOGY, 2021, 33 (01) : E22 - E30
  • [27] Trends in incidence and survival from anal cancer and incidence of high-grade anal intraepithelial neoplasia in Denmark
    Urbute, Aivara
    Munk, Christian
    Sand, Freja L.
    Belmonte, Federica
    Kjaer, Susanne K.
    CANCER EPIDEMIOLOGY, 2022, 77
  • [28] Defining Prognostic Biomarkers and Optimal Adjuvant Treatment for Gynecologic Cancer
    Beriwal, Sushil
    Klopp, Ann
    Mell, Loren
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (01): : 1 - 4
  • [29] Integration of Cancer Genomics With Treatment Selection From the Genome to Predictive Biomarkers
    Ow, Thomas J.
    Sandulache, Vlad C.
    Skinner, Heath D.
    Myers, Jeffrey N.
    CANCER, 2013, 119 (22) : 3914 - 3928
  • [30] Biomarkers for Prostate Cancer: From Diagnosis to Treatment
    Chen, Jia-Yan
    Wang, Pei-Yan
    Liu, Ming-Zhu
    Lyu, Feng
    Ma, Ming-Wei
    Ren, Xue-Ying
    Gao, Xian-Shu
    DIAGNOSTICS, 2023, 13 (21)